Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

9vHPV vaccineOngoingActive not recruitingPhase 3Open NCT05314023 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…